BW

ZAC polyclonal Antibody | BS62528

(No reviews yet) Write a Review
SKU:
BW-BS62528
Availability:
Usually ships in 5 working days
NULL366.00 - NULL549.00

Description

ZAC polyclonal Antibody | BS62528 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human,Mouse,Rat

Application: WB

Application Range: WB: 1:500~1:1000 IHC: 1:50~1:200

Background: Pleiomorphic adenoma gene (PLAG1) encodes a zinc finger protein and is the target gene for pleiomorphic adenomas of the salivary gland. The PLAG family of zinc finger proteins include PLAG1, ZAC1 and PLAG-like 2 (PLAGL2) . ZAC1, also known as PLAGL1, concomitantly controls apoptosis and cell cycle arrest through separate pathways. ZAC1 also acts as a positive or negative transcriptional cofactor for nuclear receptors, depending on the expression of functional p53. ZAC1 is broadly expressed in embryo, with highest expression in the liver primordium, the umbilical region and the neural tube. PLAGL1 is also expressed in normal mammary gland. PLAGL2 functions as a positive regulator of transcription and localizes to the nucleus. PLAGL2 and ZAC1 bind to the DNA consensus sequence ACGGGGGCCCCTTTA. PLAGL2 is ubiquitously expressed with particular abundance in spleen, lung and testis where it may be involved in cell cycle arrest and apoptosis of tumor cells.

Storage & Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: ZAC polyclonal Antibody detects endogenous levels of ZAC protein.

Molecular Weight: ~ 51 kDa

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: Zinc finger protein PLAGL1; Lost on transformation 1; LOT-1; Pleiomorphic adenoma-like protein 1; Tumor suppressor ZAC; PLAGL1; LOT1; ZAC

Immunogen: Synthetic peptide, corresponding to Human ZAC.

Conjugate: Unconjugated

Modification: Unmodification

Purification & Purity: The Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .

Pathway:

View AllClose